Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium Respimat vs Handihaler Ventilation Distribution in COPD
NCT05838703Phase 2Withdrawn
- Sponsor
- Duke University
- Start
- May 2023
- Primary completion
- May 2024
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of tiotropium in chronic obstructive pulmonary disease (COPD), sponsored by Duke University. Planned start May 2023; status: withdrawn.
02
Drugs
tiotropium
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT05838703.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05838703.